Company Filing History:
Years Active: 2019-2022
Title: Innovations by Namrata Patil in Cancer Treatment
Introduction
Namrata Patil is an accomplished inventor based in Sunnyvale, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for cancer. With a total of 2 patents, her work focuses on afucosylated antibodies that target specific cancer-related proteins.
Latest Patents
Namrata Patil's latest patents include groundbreaking inventions related to afucosylated anti-FGFR2IIIB antibodies. The first patent provides antibodies that bind to FGFR2IIIb, emphasizing that at least 95% of the antibodies in the composition are afucosylated. This innovation is crucial for enhancing the efficacy of cancer treatments. The second patent outlines methods for treating malignant solid tumors using these afucosylated anti-FGFR2IIIb antibodies, further demonstrating her commitment to advancing cancer therapy.
Career Highlights
Namrata Patil is currently associated with Five Prime Therapeutics, Inc., where she continues to push the boundaries of cancer research. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various forms of cancer.
Collaborations
Throughout her career, Namrata has collaborated with notable colleagues, including Thomas Harding and Kristen Pierce. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in cancer treatment.
Conclusion
Namrata Patil's contributions to the field of biotechnology, particularly in cancer treatment, are noteworthy. Her innovative patents and collaborations reflect her dedication to improving patient outcomes through advanced therapeutic strategies.